Most studies were case reports (n = 44) or case series (n = 11) reporting either cases of IRIS in patients treated for TB who were taking anti-TNFα agents for inflammatory/autoimmune disease or TB-IRIS cases treated with anti-TNFα. This evidence concerns the gene TNF and tuberculosis.